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Abstract: Introduction: The West African Ebola outbreak of 2014–2016 necessitated clinical trials in 
communities with limited health data. The EBOVAC-Salone Ebola vaccine trial is ongoing in the 
largely rural Kambia District in northern Sierra Leone. To gain a baseline insight into our local 
noncommunicable disease (NCD) epidemiology, we examined screening blood pressure (BP) 
measurements in trial volunteers. Methods: BP involved taking multiple readings using an Omron 
M6 sphygmomanometer in rested individuals. We classified BP by the European 2018 ESC/ESH 
guidelines: optimal BP, normal or high-normal BP, or hypertension (systolic ≥ 140 mmHg ± diastolic 
≥ 90 mmHg) with Grade 1, 2, or 3 (G1HT, G2HT, G3HT) severity levels. Results: Of 870 volunteers, 
220 (25.3%) had optimal BP, 236 (27.13%) had normal BP, and 250 (28.7%) had high-normal BP. The 
remaining 164 (18.9%) were hypertensive. By gender, 16.5% (109/668) of males and 27.2% (55/202) 
of females were hypertensive. Among hypertensives, 62.2% had G1HT, 18.3% had G2HT, and 19.5% 
had G3HT. Twenty-two (13.4%) were previously diagnosed, with eight on treatment. Forty-one had 
isolated systolic hypertension. The prevalence significantly increased with age (p < 0.0001), with 
5.3% (27/514) in the age-category 18–29 y, 18.6% (29/156) in 30–39 y, 49.4% (84/170) in 40–59 y, and 
80% (24/30) in ≥60 y. The severity also increased with age, with 54.9% of G1HT, 76.7% of G2HT, and 
90.7% of G3HT being aged ≥ 40 y. In total, 36.6% (60/164) of hypertensives were overweight or obese. 
Discussion: In an economically disadvantaged, Ebola-affected rural West African community 
where NCD might not traditionally be thought prevalent, almost one in five adults were found to 
be hypertensive and were mostly unaware. Additionally, nearly one in three had high-normal BP. 
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Together, these findings portend a potent, largely silent, and potentially growing NCD threat, and 
illustrate that infectious disease (ID) studies could provide opportunities for pragmatic NCD data. 
As both ID and NCD are putatively promoted by overlapping pro-inflammatory and poverty-
driven factors, a cross-paradigmatic “multiplex” approach, whereby ID studies prospectively 
incorporate NCD-related sub-studies (and vice versa), might optimize limited research resources 
for enhanced public health benefit. 
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